| Primary |
| Pain |
22.9% |
| Drug Use For Unknown Indication |
19.0% |
| Product Used For Unknown Indication |
12.4% |
| Back Pain |
5.7% |
| Drug Abuse |
5.7% |
| Abdominal Pain |
3.8% |
| Colon Cancer |
3.8% |
| Breakthrough Pain |
2.9% |
| Hypertension |
2.9% |
| Migraine |
2.9% |
| Prophylaxis |
2.9% |
| Insomnia |
1.9% |
| Lymphadenopathy |
1.9% |
| Migraine Prophylaxis |
1.9% |
| Neoplasm Malignant |
1.9% |
| Pain In Extremity |
1.9% |
| Sickle Cell Anaemia With Crisis |
1.9% |
| Transient Ischaemic Attack |
1.9% |
| Abdominal Pain Upper |
1.0% |
| Cholelithiasis |
1.0% |
|
| Respiratory Arrest |
11.4% |
| Unresponsive To Stimuli |
11.4% |
| Death |
9.1% |
| Completed Suicide |
6.8% |
| Pneumonia |
6.8% |
| Medication Error |
4.5% |
| Myocardial Infarction |
4.5% |
| Pain |
4.5% |
| Poisoning |
4.5% |
| Product Quality Issue |
4.5% |
| Pulmonary Congestion |
4.5% |
| Pulmonary Oedema |
4.5% |
| Respiratory Failure |
4.5% |
| Somnolence |
4.5% |
| Adverse Drug Reaction |
2.3% |
| Asthma |
2.3% |
| Condition Aggravated |
2.3% |
| Cyanosis |
2.3% |
| Depressed Level Of Consciousness |
2.3% |
| Drug Abuse |
2.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
35.5% |
| Pain |
21.3% |
| Product Used For Unknown Indication |
14.1% |
| Nephrolithiasis |
3.1% |
| Back Pain |
2.6% |
| Hypertension |
2.6% |
| Breakthrough Pain |
2.3% |
| Abdominal Pain |
2.1% |
| Atrial Fibrillation |
2.1% |
| Nausea |
2.1% |
| Migraine |
1.8% |
| Anaesthesia |
1.5% |
| Breast Cancer |
1.3% |
| Induction Of Anaesthesia |
1.3% |
| Renal Pain |
1.3% |
| Coronary Artery Disease |
1.0% |
| Ill-defined Disorder |
1.0% |
| Pancreatitis Relapsing |
1.0% |
| Prophylaxis |
1.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
|
| Completed Suicide |
16.0% |
| Death |
8.6% |
| Vomiting |
8.6% |
| Poisoning |
7.4% |
| Drug Abuse |
6.2% |
| Medication Error |
6.2% |
| Suicide Attempt |
6.2% |
| Faecaloma |
4.9% |
| Respiratory Arrest |
4.9% |
| Unresponsive To Stimuli |
4.9% |
| Drug Hypersensitivity |
3.7% |
| Somnolence |
3.7% |
| Hyperaesthesia |
2.5% |
| Pain |
2.5% |
| Pulse Absent |
2.5% |
| Serotonin Syndrome |
2.5% |
| Sopor |
2.5% |
| Substance Abuse |
2.5% |
| Weight Bearing Difficulty |
2.5% |
| Abdominal Discomfort |
1.2% |
|
| Concomitant |
| Drug Use For Unknown Indication |
36.6% |
| Product Used For Unknown Indication |
27.0% |
| Pain |
9.6% |
| Hypertension |
3.2% |
| Rheumatoid Arthritis |
3.1% |
| Depression |
2.5% |
| Anxiety |
2.1% |
| Nausea |
1.9% |
| Gait Disturbance |
1.8% |
| Prophylaxis |
1.5% |
| Crohn's Disease |
1.4% |
| Blood Cholesterol Abnormal |
1.2% |
| Breast Cancer |
1.1% |
| Gastrooesophageal Reflux Disease |
1.1% |
| Anticoagulant Therapy |
1.1% |
| Back Pain |
1.0% |
| Constipation |
1.0% |
| Diffuse Large B-cell Lymphoma |
1.0% |
| Colorectal Cancer Metastatic |
0.9% |
| Multiple Myeloma |
0.9% |
|
| Vomiting |
16.8% |
| Weight Decreased |
7.5% |
| Weight Increased |
7.5% |
| Urinary Tract Infection |
6.5% |
| Pain |
6.1% |
| Pulmonary Embolism |
6.1% |
| Wound Infection Staphylococcal |
6.1% |
| Drug Ineffective |
4.7% |
| Death |
4.2% |
| Urinoma |
4.2% |
| Nausea |
3.7% |
| Pneumonia |
3.7% |
| Pyrexia |
3.7% |
| Febrile Neutropenia |
3.3% |
| Thrombocytopenia |
3.3% |
| Platelet Disorder |
2.8% |
| Vision Blurred |
2.8% |
| Intestinal Obstruction |
2.3% |
| Small Intestinal Obstruction |
2.3% |
| Visual Impairment |
2.3% |
|
| Interacting |
| Product Used For Unknown Indication |
50.0% |
| Delirium |
12.5% |
| Bone Pain |
8.3% |
| Hormone Therapy |
8.3% |
| Neoplasm Malignant |
8.3% |
| Arthralgia |
4.2% |
| Pain In Extremity |
4.2% |
| Sedation |
4.2% |
|
|
